Creating new non-addictive pain relief options for neuropathic pain
Development of non-opioid, non-addictive analgesics for treating neuropathic pain
['FUNDING_R01'] · NORTHEASTERN UNIVERSITY · NIH-11058796
This study is working on creating new pain relief medications that help with nerve pain without using opioids, so they won't be addictive and can provide safe relief for patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHEASTERN UNIVERSITY (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11058796 on ClinicalTrials.gov |
What this research studies
This research focuses on developing new types of pain relief medications that do not rely on opioids and are not addictive. It aims to create dual-action compounds that can effectively manage neuropathic pain by targeting specific receptors in the body without causing the side effects commonly associated with traditional pain medications. The research involves synthesizing novel compounds and testing their effectiveness in preclinical models to ensure they provide safe and effective pain relief. Patients may benefit from these new treatments that aim to alleviate pain without the risk of addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing neuropathic pain who are seeking alternative pain relief methods.
Not a fit: Patients who do not suffer from neuropathic pain or have other underlying conditions that contraindicate participation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer pain management options for patients suffering from neuropathic pain.
How similar studies have performed: Previous research has shown promise in developing non-addictive pain relief methods, but this approach using dualsteric modulators is relatively novel.
Where this research is happening
BOSTON, UNITED STATES
- NORTHEASTERN UNIVERSITY — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: THAKUR, GANESH A — NORTHEASTERN UNIVERSITY
- Study coordinator: THAKUR, GANESH A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: addictive disorder